Sartorius Stedim Biotech S.A. (EPA:DIM)
166.45
-3.70 (-2.17%)
Mar 6, 2026, 5:00 PM CET
Sartorius Stedim Biotech Employees
As of December 31, 2025, Sartorius Stedim Biotech had 10,265 total employees, including 9,753 full-time and 512 part-time employees. The number of employees increased by 364 or 3.68% compared to the previous year.
Employees
10,265
Change (1Y)
364
Growth (1Y)
3.68%
Revenue / Employee
€296,483
Profits / Employee
€26,536
Market Cap
16.55B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10,265 | 364 | 3.68% |
| Dec 31, 2024 | 9,901 | -761 | -7.14% |
| Dec 31, 2023 | 10,662 | -1,272 | -10.66% |
| Dec 31, 2022 | 11,934 | 1,525 | 14.65% |
| Dec 31, 2021 | 10,409 | 2,843 | 37.58% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 200,000 |
| Sanofi | 74,846 |
| Ipsen | 5,358 |
| Eurofins Scientific SE | 65,000 |
| bioMérieux | 14,754 |
| ABIVAX Société Anonyme | 67 |
| Virbac | 6,365 |
| emeis Société anonyme | 83,500 |
Sartorius Stedim Biotech News
- 17 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - Sartorius Stedim Biotech SA (SDMHF) Q4 2025 Earnings Call Highlights: Strong Profit Growth and ... - GuruFocus
- 4 weeks ago - Sartorius Stedim Biotech S.A. (SRTOY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Preliminary Q4 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 4 weeks ago - Sartorius Stedim Biotech S.A. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Sartorius Stedim Biotech FY25 Results Climb; Sees Growth In FY26, Beyond - Nasdaq
- 4 weeks ago - Sartorius Stedim Biotech S.A. Non-GAAP EPS of €4.40, revenue of €2.97B; initates FY26 outlook - Seeking Alpha
- 7 months ago - Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing - Business Wire